![](https://www.businessmarketinsights.com/assets/img/reports-icon.png)
Europe Pharmaceutical Isolator Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (Open Isolator and Closed Isolator), Pressure (Positive Pressure and Negative Pressure), Configuration (Floor Standing, Modular, Mobile, and Compact), Application (Aseptic Isolators, Containment Isolators, Sampling and Weighing Isolators, Fluid Dispensing Isolators, and Others), and End User (Hospitals, Pharmaceutical and Biotechnology Companies, Research and Academic Laboratories, and Others)
Market Introduction
Europe region includes France, Germany, Italy, Spain, United Kingdom, and rest of Europe. Germany led the market during forecast period. According to the International Trade Administration (ITA), in 2017, the pharmaceutical market in Germany accounted for US$ 60.5 billion. It will remain one of the most attractive destinations for the pharmaceutical industry across the globe over the coming years. The demand for pharmaceuticals in Germany is growing significantly, owing to the rising geriatric population, the increasing prevalence of chronic diseases, and increasing order for the production of new molecules for various therapeutic areas to fulfill the unmet condition. The significant research advancements are providing a spur to the growth of the pharmaceutical isolators market in Germany. There are numerous international and domestic pharmaceutical players present in Germany. Some of the local critical players established in Germany include BASF, Bayer, and Hoechst who are using isolators in sterilized manufacturing process. German CMOs provide their production services to large pharmaceutical companies and to small-scale biotech companies that make them the leader in Europe but globally. In 2014, there were more than 640 pharmaceutical companies present in Germany. These pharmaceutical companies are majorly focusing on R&D to develop new drugs for various therapeutic applications. The expenditures for R&D have increased by pharmaceutical companies in Germany. For instance, according to a report published by the European Federation of Pharmaceutical Industries and Associations (EFPIA) in 2018, the pharmaceutical R&D expenditure in Germany has increased from US$ 7,100.6 million (6216 € million) in 2015 to US$ 7,113.2 million in 2016 (6,227€ million). It is expected to increase the demand for outsourcing activities to CROs and hence to drive the market.
In case of COVID-19, Europe is highly affected specially France and Russia. Europe has strengthened its efforts to serve through its pharmaceutical industry. For instance, On January 4, 2021, Moderna and Recipharm Announce COVID-19 vaccine supply agreement. The companies have entered into an agreement to support the formulation and fill/finish of Moderna’s COVID-19 vaccine supply outside of the United States. According to a Recipharm press release, the manufacturing will take place at Recipharm’s drug product manufacturing facility in France and, subject to regulatory approval in countries outside of the US, the supply will begin in early 2021. On December 9, 2020, CureVac N.V, a global clinical-stage biopharmaceutical company developing a new class of transformative medicines based on messenger ribonucleic acid (mRNA), and Fareva announced an agreement regarding the fill & finish manufacturing of CureVac´s COVID-19 vaccine candidate, CVnCoV, at Fareva’s Pau and Val-de-Reuil-sites in France. Wockhardt Ltd has entered into an agreement with the UK government to fill and finish covid-19 vaccine vials at its subsidiary CP Pharmaceuticals’ facility based in Wrexham, North Wales. As per the agreement, Wockhardt will fill finish the vaccines in vials after it receives the bulk products from the company manufacturing successful vaccines. All these developments will support the market growth for pharmaceutical isolators during the pandemic.
![](https://www.theinsightpartners.com//assets/rdimages/25279-img1.png)
Get more information on this report :
Market Overview and Dynamics
The Europe pharmaceutical isolator market is expected to grow from US$ 1,741.57 million in 2021 to US$ 3,114.23 million by 2028; it is estimated to grow at a CAGR of 8.7% from 2021 to 2028. In the pharmaceutical industry. automation of aseptic procedures, with the help of dedicated workstations and system software, has lowered manual interference in manufacturing processes, increased efficiency, and enabled researchers to concentrate on important tasks and avoid human errors. The increased adoption of automated pharmaceutical isolators can also be attributed to factors such as maintaining stringent regulatory compliance, increasing efficiency and productivity, and driving the safety and integrity of pharmaceutical products. The advancement of automation, including robotics, is one area of progress for aseptic fill-finish processes. Recent emerging technologies in aseptic processing, such as advanced isolators, robotics, and increased automation, are expected to change the industry and markedly reduced contamination risks for sterile products. Conventional isolator systems routinely require many operators at a time when regulators have long stated the need for aseptic filling systems to use robotics and reduce human interaction in drug manufacturing. Gloveless isolator technology for biopharmaceutical processes is getting traction in the industry. Future trends in technology are making isolators increasingly attractive for aseptic operations. Automated isolators are a perfect fit for parenteral solution products that can ensure the highest level of aseptic conditions. Therefore, growing use of automation is expected to fuel the Europe market growth.
Key Market Segments
In terms of type, the open isolator segment accounted for the largest share of the Europe pharmaceutical isolator market in 2020. In terms of pressure, the positive pressure segment held a larger market share of the Europe pharmaceutical isolator market in 2020. In terms of configuration, the floor standing segment held a larger market share of the Europe pharmaceutical isolator market in 2020. In terms of application, the aseptic isolators segment held a larger market share of the Europe pharmaceutical isolator market in 2020. Further, the pharmaceutical and biotechnology companies segment held a larger share of the Europe pharmaceutical isolator market based on end user in 2020.
Major Sources and Companies Listed
A few major primary and secondary sources referred to for preparing this report on the Europe pharmaceutical isolator market are company websites, annual reports, financial reports, national government documents, and statistical database, among others. Major companies listed in the report are Azbil Telstar, Bioquell (Ecolab Solution), Comecer, Fedegari Autoclavi S.p.A., Getinge AB, Hosokawa Micron Group, ITECO S.R.L., Nuaire Inc., and Schematic Engineering Industries.
Reasons to buy report
- To understand the Europe pharmaceutical isolator market landscape and identify market segments that are most likely to guarantee a strong return
- Stay ahead of the race by comprehending the ever-changing competitive landscape for Europe pharmaceutical isolator market
- Efficiently plan M&A and partnership deals in Europe pharmaceutical isolator market by identifying market segments with the most promising probable sales
- Helps to take knowledgeable business decisions from perceptive and comprehensive analysis of market performance of various segment form Europe pharmaceutical isolator market
- Obtain market revenue forecast for market by various segments from 2021-2028 in Europe region.
Europe Pharmaceutical Isolator Market Segmentation
Europe Pharmaceutical Isolator Market - By Type
- Open Isolators
- Closed Isolators
Europe Pharmaceutical Isolator Market - By Pressure
- Positive Pressure
- Negative Pressure
Europe Pharmaceutical Isolator Market - By Configuration
- Floor Standing
- Modular
- Compact
- Mobile
Europe Pharmaceutical Isolator Market - By Application
- Aseptic
- Sampling & Weighing
- Fluid Dispensing
- Containment
- Others
Europe Pharmaceutical Isolator Market – By End User
- Pharmaceutical and Biotechnology Companies
- Hospitals
- Research and Academic Laboratories
- Other
Europe Pharmaceutical Isolator Market - By Country
- Germany
- France
- Italy
- UK
- Spain
- Rest of Europe
Europe Pharmaceutical Isolator Market - Company Profiles
- Azbil Telstar
- Bioquell (Ecolab Solution)
- Comecer
- Fedegari Autoclavi S.p.A.
- Getinge AB
- Hosokawa Micron Group
- ITECO S.R.L.
- Nuaire Inc.
- Schematic Engineering Industries
TABLE OF CONTENTS
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Europe Pharmaceutical Isolator Market – By Type
1.3.2 Europe Pharmaceutical Isolator Market – By Pressure
1.3.3 Europe Pharmaceutical Isolator Market – By Configuration
1.3.4 Europe Pharmaceutical Isolator Market – By Application
1.3.5 Europe Pharmaceutical Isolator Market – By End User
1.3.6 Europe Pharmaceutical Isolator Market – By Country
2. Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Market Landscape
4.1 Overview
4.2 Europe PEST Analysis
4.3 Experts Opinion
5. Europe Pharmaceutical Isolator Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Rising investments by Pharmaceutical and Biotechnology Industry
5.1.2 Rules and Regulations to Support Adoption of Pharmaceutical Isolators
5.2 Market Restraint
5.2.1 Expensive Operations and Maintenance
5.3 Market Opportunities
5.3.1 Increasing Pharmaceutical and Biotechnological Industries
5.4 Future Trends
5.4.1 Growing Adoption of Automation in Pharmaceutical Isolator
5.5 Impact Analysis
6. Pharmaceutical Isolator Market – Europe Analysis
6.1 Europe Pharmaceutical Isolator Market Revenue Forecast and Analysis
7. Europe Pharmaceutical Isolator Market Analysis and forecasts to 2028 –By Type
7.1 Overview
7.2 Europe Pharmaceutical Isolator Market Share by Type 2021 & 2028 (%)
7.3 Open Isolator
7.3.1 Overview
7.3.2 Open Isolator Market Revenue and Forecast to 2028 (US$ Mn)
7.4 Closed Isolator
7.4.1 Overview
7.4.2 Closed Isolator Market Revenue and Forecast to 2028 (US$ Mn)
8. Europe Pharmaceutical Isolator Market Analysis and Forecasts to 2028 –By Pressure
8.1 Overview
8.2 Europe Pharmaceutical Isolator Market Share by Pressure 2021 & 2028 (%)
8.3 Positive Pressure
8.3.1 Overview
8.3.2 Positive Pressure Market Revenue and Forecast to 2028 (US$ Mn)
8.4 Negative Pressure
8.4.1 Overview
8.4.2 Negative Pressure Market Revenue and Forecast to 2028 (US$ Mn)
9. Europe Pharmaceutical Isolator Market Analysis and Forecasts to 2028 –By Configuration
9.1 Overview
9.2 Europe Pharmaceutical Isolator Market Share by Configuration 2021 & 2028 (%)
9.3 Floor Standing
9.3.1 Overview
9.3.2 Floor Standing Market Revenue and Forecast to 2028 (US$ Mn)
9.4 Modular
9.4.1 Overview
9.4.2 Modular Market Revenue and Forecast to 2028 (US$ Mn)
9.5 Compact
9.5.1 Overview
9.5.2 Compact Market Revenue and Forecast to 2028 (US$ Mn)
9.6 Mobile
9.6.1 Overview
9.6.2 Mobile Market Revenue and Forecast to 2028 (US$ Mn)
10. Europe Pharmaceutical Isolator Market Analysis and Forecasts to 2028 –By Application
10.1 Overview
10.2 Europe Pharmaceutical Isolator Market Share by Application 2021 & 2028 (%)
10.3 Aseptic Isolators
10.3.1 Overview
10.3.2 Aseptic Isolators Market Revenue and Forecast to 2028 (US$ Mn)
10.4 Sampling and Weighing Isolators
10.4.1 Overview
10.4.2 Sampling and Weighing Isolators Market Revenue and Forecast to 2028 (US$ Mn)
10.5 Fluid Dispensing Isolators
10.5.1 Overview
10.5.2 Fluid Dispensing Isolators Market Revenue and Forecast to 2028 (US$ Mn)
10.6 Containment Isolators
10.6.1 Overview
10.6.2 Containment Isolators Market Revenue and Forecast to 2028 (US$ Mn)
10.7 Others
10.7.1 Overview
10.7.2 Others Market Revenue and Forecast to 2028 (US$ Mn)
11. Europe Pharmaceutical Isolator Market Analysis and Forecasts to 2028 –By End User
11.1 Overview
11.2 Europe Pharmaceutical Isolator Market Share by End User 2021 & 2028 (%)
11.3 Pharmaceuticals and Biotechnology Companies
11.3.1 Overview
11.3.2 Pharmaceutical And Biotechnology Market Revenue and Forecast to 2028 (US$ Mn)
11.4 Hospitals
11.4.1 Overview
11.4.2 Hospitals Market Revenue and Forecast to 2028 (US$ Mn)
11.5 Research and Academic Laboratories
11.5.1 Overview
11.5.2 Research and Academic Laboratories Market Revenue and Forecast to 2028 (US$ Mn)
11.6 Others
11.6.1 Overview
11.6.2 Others Market Revenue and Forecast to 2028 (US$ Mn)
12. Europe Pharmaceutical Isolator Market – Country Analysis
12.1 Europe: Pharmaceutical Isolator Market
12.1.1 Europe: Pharmaceutical Isolator Market, by Country, 2021 & 2028 (%)
12.1.1.1 UK: Pharmaceutical Isolator Market – Revenue and Forecast to 2028 (USD Million)
12.1.1.1.1 UK: Pharmaceutical Isolator Market – Revenue and Forecast to 2028 (USD Million)
12.1.1.1.2 UK: Pharmaceutical Isolator Market , by Type – Revenue and Forecast to 2028 (USD Million)
12.1.1.1.3 UK: Pharmaceutical Isolator Market , by Pressure – Revenue and Forecast to 2028 (USD Million)
12.1.1.1.4 UK: Pharmaceutical Isolator Market , by Configuration – Revenue and Forecast to 2028 (USD Million)
12.1.1.1.5 UK: Pharmaceutical Isolator Market , by Application – Revenue and Forecast to 2028 (USD Million)
12.1.1.1.6 UK: Pharmaceutical Isolator Market , by End User – Revenue and Forecast to 2028 (USD Million)
12.1.1.2 Germany: Pharmaceutical Isolator Market – Revenue and Forecast to 2028 (USD Million)
12.1.1.2.1 Germany: Pharmaceutical Isolator Market – Revenue and Forecast to 2028 (USD Million)
12.1.1.2.2 Germany: Pharmaceutical Isolator Market , by Type– Revenue and Forecast to 2028 (USD Million)
12.1.1.2.3 Germany: Pharmaceutical Isolator Market , by Pressure– Revenue and Forecast to 2028 (USD Million)
12.1.1.2.4 Germany: Pharmaceutical Isolator Market , by Configuration– Revenue and Forecast to 2028 (USD Million)
12.1.1.2.5 Germany: Pharmaceutical Isolator Market , by Application– Revenue and Forecast to 2028 (USD Million)
12.1.1.2.6 Germany: Pharmaceutical Isolator Market , by End User– Revenue and Forecast to 2028 (USD Million)
12.1.1.3 France: Pharmaceutical Isolator Market - Revenue and Forecasts to 2028 (USD Million)
12.1.1.3.1 France: Pharmaceutical Isolator Market – Revenue and Forecast to 2028 (USD Million)
12.1.1.3.2 France: Pharmaceutical Isolator Market , by Type– Revenue and Forecast to 2028 (USD Million)
12.1.1.3.3 France: Pharmaceutical Isolator Market , by Pressure– Revenue and Forecast to 2028 (USD Million)
12.1.1.3.4 France: Pharmaceutical Isolator Market , by Configuration– Revenue and Forecast to 2028 (USD Million)
12.1.1.3.5 France: Pharmaceutical Isolator Market , by Application– Revenue and Forecast to 2028 (USD Million)
12.1.1.3.6 France: Pharmaceutical Isolator Market , by End User– Revenue and Forecast to 2028 (USD Million)
12.1.1.4 Spain: Pharmaceutical Isolator Market – Revenue and Forecast to 2028 (USD Million)
12.1.1.4.1 Spain: Pharmaceutical Isolator Market – Revenue and Forecast to 2028 (USD Million)
12.1.1.4.2 Spain: Pharmaceutical Isolator Market , by Type – Revenue and Forecast to 2028 (USD Million)
12.1.1.4.3 Spain: Pharmaceutical Isolator Market , by Pressure – Revenue and Forecast to 2028 (USD Million)
12.1.1.4.4 Spain: Pharmaceutical Isolator Market , by Configuration – Revenue and Forecast to 2028 (USD Million)
12.1.1.4.5 Spain: Pharmaceutical Isolator Market , by Application– Revenue and Forecast to 2028 (USD Million)
12.1.1.4.6 Spain: Pharmaceutical Isolator Market, by End User – Revenue and Forecast to 2028 (USD Million)
12.1.1.5 Italy: Pharmaceutical Isolator Market – Revenue and Forecast to 2028 (USD Million)
12.1.1.5.1 Italy: Pharmaceutical Isolator Market – Revenue and Forecast to 2028 (USD Million)
12.1.1.5.2 Italy: Pharmaceutical Isolator Market , by Type– Revenue and Forecast to 2028 (USD Million)
12.1.1.5.3 Italy: Pharmaceutical Isolator Market , by Pressure– Revenue and Forecast to 2028 (USD Million)
12.1.1.5.4 Italy: Pharmaceutical Isolator Market , by Configuration– Revenue and Forecast to 2028 (USD Million)
12.1.1.5.5 Italy: Pharmaceutical Isolator Market , by Application– Revenue and Forecast to 2028 (USD Million)
12.1.1.5.6 Italy: Pharmaceutical Isolator Market , by End User– Revenue and Forecast to 2028 (USD Million)
12.1.1.6 Rest of Europe: Pharmaceutical Isolator Market – Revenue and Forecast to 2028 (USD Million)
12.1.1.6.1 Rest of Europe: Pharmaceutical Isolator Market – Revenue and Forecast to 2028 (USD Million)
12.1.1.6.2 Rest of Europe: Pharmaceutical Isolator Market , by Type – Revenue and Forecast to 2028 (USD Million)
12.1.1.6.3 Rest of Europe: Pharmaceutical Isolator Market , by Pressure – Revenue and Forecast to 2028 (USD Million)
12.1.1.6.4 Rest of Europe: Pharmaceutical Isolator Market , by Configuration – Revenue and Forecast to 2028 (USD Million)
12.1.1.6.5 Rest of Europe: Pharmaceutical Isolator Market , by Application– Revenue and Forecast to 2028 (USD Million)
12.1.1.6.6 Rest of Europe: Pharmaceutical Isolator Market , by End User – Revenue and Forecast to 2028 (USD Million)
13. Impact of COVID-19 Pandemic on Europe Pharmaceutical Isolator Market
13.1 Europe: Impact Assessment of COVID-19 Pandemic
14. Industry Landscape
14.1 Overview
14.2 Organic Developments
14.2.1 Overview
14.3 Inorganic Developments
14.3.1 Overview
15. Company Profiles
15.1 ITECO S.R.L.
15.1.1 Key Facts
15.1.2 Business Description
15.1.3 Products and Services
15.1.4 Financial Overview
15.1.5 SWOT Analysis
15.1.6 Key Developments
15.2 Schematic Engineering Industries
15.2.1 Key Facts
15.2.2 Business Description
15.2.3 Products and Services
15.2.4 Financial Overview
15.2.5 SWOT Analysis
15.2.6 Key Developments
15.3 Nuaire Inc.
15.3.1 Key Facts
15.3.2 Business Description
15.3.3 Products and Services
15.3.4 Financial Overview
15.3.5 SWOT Analysis
15.3.6 Key Developments
15.4 Comecer
15.4.1 Key Facts
15.4.2 Business Description
15.4.3 Products and Services
15.4.4 Financial Overview
15.4.5 SWOT Analysis
15.4.6 Key Developments
15.5 Getinge AB
15.5.1 Key Facts
15.5.2 Business Description
15.5.3 Products and Services
15.5.4 Financial Overview
15.5.5 SWOT Analysis
15.5.6 Key Developments
15.6 Hosokawa Micron Group
15.6.1 Key Facts
15.6.2 Business Description
15.6.3 Products and Services
15.6.4 Financial Overview
15.6.5 SWOT Analysis
15.6.6 Key Developments
15.7 Fedegari Autoclavi S.p.A.
15.7.1 Key Facts
15.7.2 Business Description
15.7.3 Products and Services
15.7.4 Financial Overview
15.7.5 SWOT Analysis
15.7.6 Key Developments
15.8 Azbil Telstar
15.8.1 Key Facts
15.8.2 Business Description
15.8.3 Products and Services
15.8.4 Financial Overview
15.8.5 SWOT Analysis
15.8.6 Key Developments
15.9 Bioquell ( Ecolab Solution)
15.9.1 Key Facts
15.9.2 Business Description
15.9.3 Products and Services
15.9.4 Financial Overview
15.9.5 SWOT Analysis
15.9.6 Key Developments
16. Appendix
16.1 About The Insight Partners
16.2 Glossary of Terms
LIST OF TABLES
Table 1. Europe Pharmaceutical Isolator Market – Revenue and Forecast to 2028 (USD Million)
Table 2. UK Pharmaceutical Isolator Market , by Type – Revenue and Forecast to 2028 (USD Million)
Table 3. UK Pharmaceutical Isolator Market , by Pressure – Revenue and Forecast to 2028 (USD Million)
Table 4. UK Pharmaceutical Isolator Market , by Configuration – Revenue and Forecast to 2028 (USD Million)
Table 5. UK Pharmaceutical Isolator Market , by Application – Revenue and Forecast to 2028 (USD Million)
Table 6. UK Pharmaceutical Isolator Market , by End User – Revenue and Forecast to 2028 (USD Million)
Table 7. Germany Pharmaceutical Isolator Market , by Type– Revenue and Forecast to 2028 (USD Million)
Table 8. Germany Pharmaceutical Isolator Market , by Pressure– Revenue and Forecast to 2028 (USD Million)
Table 9. Germany Pharmaceutical Isolator Market , by Configuration– Revenue and Forecast to 2028 (USD Million)
Table 10. Germany Pharmaceutical Isolator Market , by Application – Revenue and Forecast to 2028 (USD Million)
Table 11. Germany Pharmaceutical Isolator Market , by End User– Revenue and Forecast to 2028 (USD Million)
Table 12. France Pharmaceutical Isolator Market , by Type– Revenue and Forecast to 2028 (USD Million)
Table 13. France Pharmaceutical Isolator Market , by Pressure– Revenue and Forecast to 2028 (USD Million)
Table 14. France Pharmaceutical Isolator Market , by Configuration– Revenue and Forecast to 2028 (USD Million)
Table 15. France Pharmaceutical Isolator Market , by Application– Revenue and Forecast to 2028 (USD Million)
Table 16. France Pharmaceutical Isolator Market , by End User– Revenue and Forecast to 2028 (USD Million)
Table 17. Spain Pharmaceutical Isolator Market , by Type – Revenue and Forecast to 2028 (USD Million)
Table 18. Spain Pharmaceutical Isolator Market , by Pressure – Revenue and Forecast to 2028 (USD Million)
Table 19. Spain Pharmaceutical Isolator Market , by Configuration – Revenue and Forecast to 2028 (USD Million)
Table 20. Spain Pharmaceutical Isolator Market , by Application – Revenue and Forecast to 2028 (USD Million)
Table 21. Spain Pharmaceutical Isolator Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 22. Italy Pharmaceutical Isolator Market , by Type – Revenue and Forecast to 2028 (USD Million)
Table 23. Italy Pharmaceutical Isolator Market , by Pressure – Revenue and Forecast to 2028 (USD Million)
Table 24. Italy Pharmaceutical Isolator Market , by Configuration – Revenue and Forecast to 2028 (USD Million)
Table 25. Italy Pharmaceutical Isolator Market , by Application – Revenue and Forecast to 2028 (USD Million)
Table 26. Italy Pharmaceutical Isolator Market , by End User – Revenue and Forecast to 2028 (USD Million)
Table 27. Rest of Europe Pharmaceutical Isolator Market , by Type – Revenue and Forecast to 2028 (USD Million)
Table 28. Rest of Europe Pharmaceutical Isolator Market , by Pressure – Revenue and Forecast to 2028 (USD Million)
Table 29. Rest of Europe Pharmaceutical Isolator Market , by Configuration – Revenue and Forecast to 2028 (USD Million)
Table 30. Rest of Europe Pharmaceutical Isolator Market , by Application – Revenue and Forecast to 2028 (USD Million)
Table 31. Rest of Europe Pharmaceutical Isolator Market , by End User – Revenue and Forecast to 2028 (USD Million)
Table 32. Organic Developments Done By Companies
Table 33. Inorganic Developments Done by Companies
Table 34. Glossary of Terms
LIST OF FIGURES
Figure 1. Europe Pharmaceutical Isolator Market Segmentation
Figure 2. Europe Pharmaceutical Isolator Market Segmentation, By Country
Figure 3. Europe Pharmaceutical Isolator Market Overview
Figure 4. Open Isolators Segment led the Market in 2021
Figure 5. Germany to Show Significant Growth During Forecast Period
Figure 6. Europe and PEST Analysis
Figure 7. Europe Pharmaceutical Isolator Market Impact Analysis of Driver and Restraints
Figure 8. Europe Pharmaceutical Isolator Market – Revenue Forecast and Analysis
Figure 9. Europe Pharmaceutical Isolator Market Share by Type 2021 & 2028 (%)
Figure 10. Europe Open Isolator Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 11. Europe Closed Isolator Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 12. Europe Pharmaceutical Isolator Market Share by Pressure 2021 & 2028 (%)
Figure 13. Europe Positive Pressure Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 14. Europe Negative Pressure Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 15. Europe Pharmaceutical Isolator Market Share by Configuration 2021 & 2028 (%)
Figure 16. Europe Floor Standing Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 17. Europe Modular Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 18. Europe Compact Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 19. Europe Mobile Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 20. Europe Pharmaceutical Isolator Market Share by Application 2021 & 2028 (%)
Figure 21. Europe Aseptic Isolators Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 22. Europe Sampling and Weighing Isolators Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 23. Europe Fluid Dispensing Isolators Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 24. Europe Containment Isolators Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 25. Europe Others Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 26. Europe Pharmaceutical Isolator Market Share by End User 2021 & 2028 (%)
Figure 27. Europe Pharmaceutical and Biotechnology Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 28. Europe Hospitals Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 29. Europe Research and Academic Laboratories Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 30. Europe Others Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 31. Europe: Pharmaceutical Isolator Market, by Key Country – Revenue (2021) (USD Million)
Figure 32. Europe: Pharmaceutical Isolator Market, by Country, 2021 & 2028 (%)
Figure 33. UK: Pharmaceutical Isolator Market – Revenue and Forecast to 2028 (USD Million)
Figure 34. Germany: Pharmaceutical Isolator Market – Revenue and Forecast to 2028 (USD Million)
Figure 35. France: Pharmaceutical Isolator Market – Revenue and Forecast to 2028 (USD Million)
Figure 36. Spain: Pharmaceutical Isolator Market – Revenue and Forecast to 2028 (USD Million)
Figure 37. Italy: Pharmaceutical Isolator Market – Revenue and Forecast to 2028 (USD Million)
Figure 38. Rest of Europe: Pharmaceutical Isolator Market – Revenue and Forecast to 2028 (USD Million)
Figure 39. Impact of COVID-19 Pandemic in European Country Markets
- Azbil Telstar
- Bioquell (Ecolab Solution)
- Comecer
- Fedegari Autoclavi S.p.A.
- Getinge AB
- Hosokawa Micron Group
- ITECO S.R.L.
- Nuaire Inc.
- Schematic Engineering Industries
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Europe pharmaceutical isolator market.
- Highlights key business priorities in order to assist companies to realign their business strategies
- The key findings and recommendations highlight crucial progressive industry trends in Europe pharmaceutical isolator market, thereby allowing players across the value chain to develop effective long-term strategies
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
- Scrutinize in-depth Europe market trends and outlook coupled with the factors driving the pharmaceutical isolator market, as well as those hindering it
- Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution